Incubate Coalition

As Japanese Prime Minister Sanae Takaichi prepares for a summit with President Trump in Washington next week, Incubate is proud to reflect on the deep and sustained engagement we have built with Japan's life sciences ecosystem and to reaffirm our commitment to advancing the US-Japan biotech relationship for years to come. For Incubate, Japan is not a new frontier. It is a long-standing partner, and our work there has been built deliberately, engagement by engagement, over the past several...

WASHINGTON (December 19) –   Today, the Center for Medicare and Medicaid Innovation (CMMI) announced a proposed series of Medicare drug pricing demonstrations affecting some Part B  and Part D  medicines, respectively. The Global Benchmark for Efficient Drug Pricing (GLOBE) and Guarding U.S. Medicare Against Rising Drug Costs (GUARD) demonstrations would significantly restructure Medicare drug reimbursement and coverage, pegging Medicare Part B and Part D drug prices to those paid in foreign...

WASHINGTON (December 4)  -- This week, U.S. Senator Thom Tillis (R-NC) warned that addressing foreign drug pricing disparities and strengthening U.S. intellectual property protections are essential to preserving the nation's global leadership in life sciences. In a new episode of the Making Medicine podcast  with Incubate's executive director John Stanford, Tillis detailed a range of urgent policy priorities to maintain America's edge in biotech.  He argued that burdensome regulations can...